MedTrace Logo

Effect of Virtual Reality Training on Pain, Functional Disability, and Lumbar Reposition Error in Patients With Chronic Non-Specific Low Back Pain

NCT07577778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-11

No results posted yet for this study

Summary

This study aims to investigate the effect of virtual reality (VR) training on pain intensity, functional disability, and lumbar reposition error in patients with chronic non-specific low back pain.

Conditions

  • Non Specific Chronic Low Back Pain

Interventions

DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

TENS was applied in a prone position with electrodes placed over the painful area. Low-frequency stimulation (2-10 Hz) was used to achieve analgesic effects. Intensity was adjusted to produce a strong but comfortable tingling sensation. Each session lasted 20-60 minutes.

DRUG

Therapeutic Ultrasound

Ultrasound therapy was applied using appropriate frequency (1 MHz for deep tissues, 3 MHz for superficial tissues) and intensity (0.5-2.0 W/cm²). Continuous or pulsed modes were selected based on the condition. Each session lasted 5-10 minutes.

OTHER

Proprioceptive Exercises

Participants performed trunk stabilization exercises including supine bridge, supine bridge on Swiss ball, and prone plank. Each exercise was performed for 30 seconds with 30 seconds rest, repeated 5 times, 3 sets per session, 3 times per week.

DEVICE

Virtual Reality (VR) Training

Participants underwent VR training using Xbox 360 Kinect system. The setup included a motion sensor and projector, allowing full-body interaction through game-based activities. Training consisted of interactive games (e.g., rafting, running, ball hitting) designed to improve trunk control and motor function. Sessions were conducted twice weekly for 30 minutes over 12 weeks. Exercises included movements such as jumping, trunk tilting, and arm coordination, with progressive difficulty levels.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-03
Primary Completion
2026-04-15
Completion
2026-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07577778 on ClinicalTrials.gov